Søren Hein Sindrup

Medicine & Life Sciences

1. Analgesics 15%
2. Anticonvulsants 11%
3. Biopsy 10%
4. Chronic Inflammatory Demyelinating Polyradiculoneuropathy 49%
5. Chronic Pain 12%
6. Citalopram 37%
7. Codeine 29%
8. Cold Temperature 17%
9. Confidence Intervals 12%
10. Cross-Over Studies 35%
11. Cytochrome P-450 CYP2D6 29%
12. Demethylation 16%
13. Denmark 14%
14. Desipramine 13%
15. Diabetic Neuropathies 73%
16. Healthy Volunteers 13%
17. Hot Temperature 13%
18. Hydroxymethylglutaryl-CoA Reductase Inhibitors 10%
19. Hyperalgesia 13%
20. Imipramine 32%
21. Immunoglobulins 28%
22. Intravenous Immunoglobulins 25%
23. Levetiracetam 19%
24. Morphine 18%
25. Muscle Strength 14%
26. Nerve Fibers 18%
27. Neural Conduction 31%
28. Neuralgia 77%
29. Oxaliplatin 12%
30. Oxycodone 19%
31. Pain 67%
32. Pain Threshold 19%
33. Paroxetine 22%
34. Peripheral Nerves 20%
35. Peripheral Nervous System Diseases 16%
36. Pharmaceutical Preparations 15%
37. Pharmacokinetics 11%
38. Phenotype 19%
39. Placebos 45%
40. Polyneuropathies 100%
41. Pregabalin 15%
42. Quality of Life 11%
43. Randomized Controlled Trials 17%
44. Serotonin Uptake Inhibitors 18%
45. Skin 11%
46. Sparteine 56%
47. Sural Nerve 11%
48. Therapeutics 22%
49. Tramadol 16%
50. Type 2 Diabetes Mellitus 12%